Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ADMA Investor Alert: ADMA Biologics, Inc. Investors with Large Losses Should Contact Robbins LLP for Information About Representing the Shareholder Class
-
Robbins LLP Reminds SLP Stockholders of its Investigation into Simulation Plus, Inc.; Contact the Firm for Information
-
Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug Candidate
-
Robbins LLP is Investigating Allegations that Regencell Bioscience Holdings Limited (RGC) was Impacted by a Stock Manipulation Scheme
-
Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
-
Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
-
Robbins LLP is Investigating Allegations that Zynex, Inc. (ZYXIQ) Filed False Claims and Failed to Comply with Industry Regulations
-
Robbins LLP is Investigating Allegations that Avantor, Inc. (AVTR) Mislead Investors Regarding the Effects of Increased Competition
-
Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate
-
Robbins LLP is Investigating Allegations that Savara Inc. (SVRA) Misled Investors About the Viability of its Lead Drug Candidate